Healthtech brand, Qurex has raised over $250,000 in its pre-seed funding round. 7Square Ventures and PointOne Capital were major investors that participated in the round, a statement issued by the company said.
Qurex specialises in providing solutions for sexual health concerns. Its approach includes therapy, personalised diet plans, and exercise regimens.
Founded by Shailja Mittal and Amit Singhi, the company also offers comprehensive solutions for sexual dysfunctions that impact over 200 million people in India and 1.4 billion globally. With a focus on addressing the psychological facets of sexual health for holistic treatment.
Amit Singhi, founder of Qurex said, “This investment from 7 Square Ventures and PointOne Capital not only provides us with the resources to expand our reach but also underscores the confidence in our therapy-first approach. With this support, we're poised to make meaningful strides in improving sexual health globally, ensuring that individuals receive personalized, effective care."
The company further said that it has witnessed rapid growth with over a 30 per cent month-over-month revenue increase.
With the fresh capital infusion in start-up, it plans to further expand into new markets and develop its platform to enhance user experience. “With plans to introduce new services and technological advancements, Qurex aims to stay at the forefront of health innovation, ensuring that individuals have access to the latest advancements in sexual healthcare,” it added.
Mittal said "We are a brand which works on root cause analysis to identify the right treatment protocol for an individual rather than suggesting shilajit and ashwagandha to everyone. This investment will allow us to further develop our platform, strengthen our offerings, and deliver faster results, ultimately making a significant impact on the global sexual health market."
"We believe that Qurex has the potential to make a significant impact on the global sexual health market," said Mrinalini Arora from 7 Square Ventures. "Their commitment to innovation and destigmatisation aligns with our values, and we are excited to support them on their journey."
